Rate My Professor Caroline Chapman

Caroline Chapman, PhD, MBA, serves as Manager of Research Infrastructure and Partnerships in the Research Enterprise division of the Office of Research at the University of Western Australia (UWA). She is also Director of the Floreat Innovation Park Project in Research Operations and an Executive Committee Member of the UWA Defence and Security Institute. Chapman has over 15 years of experience in medical research and research development, beginning with laboratory-based investigations and evolving into strategic support for interdisciplinary research initiatives aimed at creating real-world impact.

Her academic background includes a BSc, a PhD in Molecular Oncology from the University of Glasgow with subsequent international postdoctoral roles, and a Master of Business Administration from Curtin University. Following research on the genetics of cardiovascular disease at the Heart Research Institute and PathWest in Western Australia, she served three years as Research Development Advisor at Edith Cowan University before joining UWA. Chapman's research specializations encompass genetic polymorphisms related to blood pressure and receptors, elevated interleukin-18 levels in metabolic syndrome, stromelysin-1 promoter polymorphisms, C-reactive protein and interleukin-18 in coronary heart disease, 15-lipoxygenase gene variants in carotid plaque, and other factors in subclinical atherosclerosis. Key publications are: "Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance" (2005), "Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population" (2005), "C-reactive protein and interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia" (2008), "IL18 Haplotypes Are Associated with Serum IL-18 Concentrations in a Population-Based Study and a Cohort of Individuals with Premature Coronary Heart Disease" (2007), "15-Lipoxygenase gene variants are associated with carotid plaque but not carotid intima-media thickness" (2008), and "A high-throughput MS-PCR method on MADGE gels for ANG II type-1 receptor A1166C polymorphism" (1999). Her publications have received over 1,100 citations.